How much does brigatinib treatment cost per month?

Brigatinib (Brigatinib), this specific drug for ALK positive non-small cell lung cancer, its treatment cost is the focus of many patients. In China, the price of brigatinib (Brigatinib) is usually about RMB 10,000 per month, but the specific cost will be affected by the patient's dosage and medical insurance reimbursement policies.

Brigatinib has been approved for marketing in China and has been successfully included in the National Reimbursement Directory, which means that patients can reduce their financial burden through medical insurance reimbursement. However, actual costs will vary based on pharmacy, hospital, and region. In order to obtain the most accurate price information and medical insurance reimbursement policies, it is recommended that patients consult the local hospital pharmacy in advance for detailed consultation.

Brigatinib (Brigatinib) is included in the National Medical Insurance Directory, providing patients with a certain degree of cost reduction. However, the specific reimbursement ratio and amount need to be determined based on the medical insurance policy and reimbursement standards of the patient's region. Generally speaking, medical insurance reimbursement can significantly reduce patients’ actual expenses.

Compared with the domestic market, the price of brigatinib abroad is generally higher. In the United States, for example, monthly treatment costs can run into the thousands of dollars. However, it is worth noting that there are some more affordable versions of generic drugs on foreign markets. For example, the monthly cost of generic drug Brigatinib in Laos is about more than one thousand yuan, which is far lower than the price of the original drug. However, when choosing generic drugs, patients should pay special attention to the quality and safety of the drug to ensure the effectiveness and reliability of the treatment.